Versigent
VGNT | NYSE
$41.91
+$0.85 (+2.07%)
Nov 2, 2026, 12:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | 8.82B | 8.31B | 8.83B | 8.02B |
Cost of Revenue | 7.73B | 7.36B | 7.76B | 7.15B |
Gross Profit | 1.09B | 947M | 1.08B | 870M |
Operating Income | 670M | 536M | 687M | 519M |
Interest Income | 3M | 4M | 4M | 1M |
Pretax Income | 540M | 473M | 596M | 505M |
Net Income | 528M | 408M | 423M | 454M |
Selling & General & Admin | 145M | 126M | 115M | 104M |
Research & Development | 274M | 285M | 273M | 247M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 419M | 411M | 388M | 351M |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.15B | 7.77B | 8.15B | 7.5B |
Income Tax Expense | -6M | 39M | 144M | 53M |
Shares Outstanding (Basic) | 71.05M | 71.05M | 71.05M | 71.05M |
Shares Outstanding (Diluted) | 71.05M | 71.05M | 71.05M | 71.05M |
EPS (Basic) | 7.43 | 5.74 | 5.95 | 6.39 |
EPS (Diluted) | 7.43 | 5.74 | 5.95 | 6.39 |
EBITDA | 897M | 738M | 892M | 710M |
EBIT | 670M | 536M | 687M | 519M |
Depreciation & Amortization | 227M | 202M | 205M | 191M |
Add to Watchlist
Select watchlists to add or remove VGNT